Global Influenza Vaccine Market Growth 2021-2026

  • receipt Report ID : 155336
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 136
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of Influenza Vaccine will have significant change from previous year. By the most conservative estimates of global Influenza Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Influenza Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Whole Virus Vaccines

Split Virus Vaccines

Subunit Vaccines

Live Attenuated Virus Vaccines

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

For Children (6 months to 3 years)

For Adults and Children over 3 years

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

CSL

GSK

Sanofi Pasteur

Mylan

AstraZeneca

Pfizer

Johnson & Johnson

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Influenza Vaccine Consumption 2016-2026

2.1.2 Influenza Vaccine Consumption CAGR by Region

2.2 Influenza Vaccine Segment by Type

2.2.1 Whole Virus Vaccines

2.2.2 Split Virus Vaccines

2.2.3 Subunit Vaccines

2.2.4 Live Attenuated Virus Vaccines

2.3 Influenza Vaccine Sales by Type

2.3.1 Global Influenza Vaccine Sales Market Share by Type (2016-2021)

2.3.2 Global Influenza Vaccine Revenue and Market Share by Type (2016-2021)

2.3.3 Global Influenza Vaccine Sale Price by Type (2016-2021)

2.4 Influenza Vaccine Segment by Application

2.4.1 For Children (6 months to 3 years)

2.4.2 For Adults and Children over 3 years

2.5 Influenza Vaccine Sales by Application

2.5.1 Global Influenza Vaccine Sale Market Share by Application (2016-2021)

2.5.2 Global Influenza Vaccine Revenue and Market Share by Application (2016-2021)

2.5.3 Global Influenza Vaccine Sale Price by Application (2016-2021)

3 Global Influenza Vaccine by Company

3.1 Global Influenza Vaccine Sales Market Share by Company

3.1.1 Global Influenza Vaccine Sales by Company (2019-2021)

3.1.2 Global Influenza Vaccine Sales Market Share by Company (2019-2021)

3.2 Global Influenza Vaccine Revenue Market Share by Company

3.2.1 Global Influenza Vaccine Revenue by Company (2019-2021)

3.2.2 Global Influenza Vaccine Revenue Market Share by Company (2019-2021)

3.3 Global Influenza Vaccine Sale Price by Company

3.4 Global Manufacturers Influenza Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Influenza Vaccine Product Location Distribution

3.4.2 Players Influenza Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Influenza Vaccine by Region

4.1 Global Influenza Vaccine by Region

4.1.1 Global Influenza Vaccine Sales by Region

4.1.2 Global Influenza Vaccine Revenue by Region

4.2 Americas Influenza Vaccine Sales Growth

4.3 APAC Influenza Vaccine Sales Growth

4.4 Europe Influenza Vaccine Sales Growth

4.5 Middle East & Africa Influenza Vaccine Sales Growth

5 Americas

5.1 Americas Influenza Vaccine Sales by Country

5.1.1 Americas Influenza Vaccine Sales by Country (2016-2021)

5.1.2 Americas Influenza Vaccine Revenue by Country (2016-2021)

5.2 Americas Influenza Vaccine Sales by Type

5.3 Americas Influenza Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Influenza Vaccine Sales by Region

6.1.1 APAC Influenza Vaccine Sales by Region (2016-2021)

6.1.2 APAC Influenza Vaccine Revenue by Region (2016-2021)

6.2 APAC Influenza Vaccine Sales by Type

6.3 APAC Influenza Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Influenza Vaccine by Country

7.1.1 Europe Influenza Vaccine Sales by Country (2016-2021)

7.1.2 Europe Influenza Vaccine Revenue by Country (2016-2021)

7.2 Europe Influenza Vaccine Sales by Type

7.3 Europe Influenza Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Influenza Vaccine by Country

8.1.1 Middle East & Africa Influenza Vaccine Sales by Country (2016-2021)

8.1.2 Middle East & Africa Influenza Vaccine Revenue by Country (2016-2021)

8.2 Middle East & Africa Influenza Vaccine Sales by Type

8.3 Middle East & Africa Influenza Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Influenza Vaccine Distributors

10.3 Influenza Vaccine Customer

11 Global Influenza Vaccine Market Forecast

11.1 Global Influenza Vaccine Forecast by Region

11.1.1 Global Influenza Vaccine Forecast by Regions (2021-2026)

11.2.2 Global Influenza Vaccine Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global Influenza Vaccine Forecast by Type

11.7 Global Influenza Vaccine Forecast by Application

12 Key Players Analysis

12.1 CSL

12.1.1 CSL CSL Company Information

12.1.2 CSL Influenza Vaccine Product Offered

12.1.3 CSL Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 CSL Main Business Overview

12.1.5 CSL Latest Developments

12.2 GSK

12.2.1 GSK Company Information

12.2.2 GSK Influenza Vaccine Product Offered

12.2.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 GSK Main Business Overview

12.2.5 GSK Latest Developments

12.3 Sanofi Pasteur

12.3.1 Sanofi Pasteur Company Information

12.3.2 Sanofi Pasteur Influenza Vaccine Product Offered

12.3.3 Sanofi Pasteur Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Sanofi Pasteur Main Business Overview

12.3.5 Sanofi Pasteur Latest Developments

12.4 Mylan

12.4.1 Mylan Company Information

12.4.2 Mylan Influenza Vaccine Product Offered

12.4.3 Mylan Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Mylan Main Business Overview

12.4.5 Mylan Latest Developments

12.5 AstraZeneca

12.5.1 AstraZeneca Company Information

12.5.2 AstraZeneca Influenza Vaccine Product Offered

12.5.3 AstraZeneca Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 AstraZeneca Main Business Overview

12.5.5 AstraZeneca Latest Developments

12.6 Pfizer

12.6.1 Pfizer Company Information

12.6.2 Pfizer Influenza Vaccine Product Offered

12.6.3 Pfizer Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Pfizer Main Business Overview

12.6.5 Pfizer Latest Developments

12.7 Johnson & Johnson

12.7.1 Johnson & Johnson Company Information

12.7.2 Johnson & Johnson Influenza Vaccine Product Offered

12.7.3 Johnson & Johnson Influenza Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Johnson & Johnson Main Business Overview

12.7.5 Johnson & Johnson Latest Developments

...

13 Research Findings and Conclusion

List of Tables

Table 1. Influenza Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Whole Virus Vaccines

Table 3. Major Players of Split Virus Vaccines

Table 4. Major Players of Subunit Vaccines

Table 5. Major Players of Live Attenuated Virus Vaccines

Table 6. Global Influenza Vaccine Sales by Type (2016-2021) & (K Doses)

Table 7. Global Influenza Vaccine Sales Market Share by Type (2016-2021)

Table 8. Global Influenza Vaccine Revenue by Type (2016-2021) & ($ million)

Table 9. Global Influenza Vaccine Revenue Market Share by Type (2016-2021)

Table 10. Global Influenza Vaccine Sale Price by Type (2016-2021)

Table 11. Global Influenza Vaccine Sales by Application (2016-2021) & (K Doses)

Table 12. Global Influenza Vaccine Sales Market Share by Application (2016-2021)

Table 13. Global Influenza Vaccine Value by Application (2016-2021)

Table 14. Global Influenza Vaccine Revenue Market Share by Application (2016-2021)

Table 15. Global Influenza Vaccine Sale Price by Application (2016-2021)

Table 16. Global Influenza Vaccine Sales by Company (2019-2021) & (K Doses)

Table 17. Global Influenza Vaccine Sales Market Share by Company (2019-2021)

Table 18. Global Influenza Vaccine Revenue by Company (2019-2021) ($ Millions)

Table 19. Global Influenza Vaccine Revenue Market Share by Company (2019-2021)

Table 20. Global Influenza Vaccine Sale Price by Company (2019-2021)

Table 21. Key Manufacturers Influenza Vaccine Producing Area Distribution and Sales Area

Table 22. Players Influenza Vaccine Products Offered

Table 23. Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Influenza Vaccine Sales by Region (2016-2021) (K Doses)

Table 27. Global Influenza Vaccine Sales Market Share by Region (2016-2021)

Table 28. Global Influenza Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 29. Global Influenza Vaccine Revenue Market Share by Region (2016-2021)

Table 30. Americas Influenza Vaccine Sales by Country (2016-2021) & (K Doses)

Table 31. Americas Influenza Vaccine Sales Market Share by Country (2016-2021)

Table 32. Americas Influenza Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 33. Americas Influenza Vaccine Revenue Market Share by Country (2016-2021)

Table 34. Americas Influenza Vaccine Sales by Type (2016-2021) & (K Doses)

Table 35. Americas Influenza Vaccine Sales Market Share by Type (2016-2021)

Table 36. Americas Influenza Vaccine Sales by Application (2016-2021) & (K Doses)

Table 37. Americas Influenza Vaccine Sales Market Share by Application (2016-2021)

Table 38. APAC Influenza Vaccine Sales by Region (2016-2021) & (K Doses)

Table 39. APAC Influenza Vaccine Sales Market Share by Region (2016-2021)

Table 40. APAC Influenza Vaccine Revenue by Region (2016-2021) & ($ Millions)

Table 41. APAC Influenza Vaccine Revenue Market Share by Region (2016-2021)

Table 42. APAC Influenza Vaccine Sales by Type (2016-2021) & (K Doses)

Table 43. APAC Influenza Vaccine Sales Market Share by Type (2016-2021)

Table 44. APAC Influenza Vaccine Sales by Application (2016-2021) & (K Doses)

Table 45. APAC Influenza Vaccine Sales Market Share by Application (2016-2021)

Table 46. Europe Influenza Vaccine Sales by Country (2016-2021) & (K Doses)

Table 47. Europe Influenza Vaccine Sales Market Share by Country (2016-2021)

Table 48. Europe Influenza Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 49. Europe Influenza Vaccine Revenue Market Share by Country (2016-2021)

Table 50. Europe Influenza Vaccine Sales by Type (2016-2021) & (K Doses)

Table 51. Europe Influenza Vaccine Sales Market Share by Type (2016-2021)

Table 52. Europe Influenza Vaccine Sales by Application (2016-2021) & (K Doses)

Table 53. Europe Influenza Vaccine Sales Market Share by Application (2016-2021)

Table 54. Middle East & Africa Influenza Vaccine Sales by Country (2016-2021) & (K Doses)

Table 55. Middle East & Africa Influenza Vaccine Sales Market Share by Country (2016-2021)

Table 56. Middle East & Africa Influenza Vaccine Revenue by Country (2016-2021) & ($ Millions)

Table 57. Middle East & Africa Influenza Vaccine Revenue Market Share by Country (2016-2021)

Table 58. Middle East & Africa Influenza Vaccine Sales by Type (2016-2021) & (K Doses)

Table 59. Middle East & Africa Influenza Vaccine Sales Market Share by Type (2016-2021)

Table 60. Middle East & Africa Influenza Vaccine Sales by Application (2016-2021) & (K Doses)

Table 61. Middle East & Africa Influenza Vaccine Sales Market Share by Application (2016-2021)

Table 62. Global Influenza Vaccine Sales Forecast by Type (2021-2026) & (K Doses)

Table 63. Global Influenza Vaccine Sales Market Share Forecast by Type (2021-2026)

Table 64. Global Influenza Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 65. Global Influenza Vaccine Revenue Market Share Forecast by Type (2021-2026)

Table 66. Global Influenza Vaccine Sales Forecast by Application (2021-2026) & (K Doses)

Table 67. Global Influenza Vaccine Sales Market Share Forecast by Application (2021-2026)

Table 68. Global Influenza Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 69. Global Influenza Vaccine Revenue Market Share Forecast by Application (2021-2026)

Table 70. CSL Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 71. CSL Influenza Vaccine Product Offered

Table 72. CSL Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 73. CSL Main Business

Table 74. CSL Latest Developments

Table 75. GSK Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 76. GSK Influenza Vaccine Product Offered

Table 77. GSK Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 78. GSK Main Business

Table 79. GSK Latest Developments

Table 80. Sanofi Pasteur Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 81. Sanofi Pasteur Influenza Vaccine Product Offered

Table 82. Sanofi Pasteur Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 83. Sanofi Pasteur Main Business

Table 84. Sanofi Pasteur Latest Developments

Table 85. Mylan Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 86. Mylan Influenza Vaccine Product Offered

Table 87. Mylan Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 88. Mylan Main Business

Table 89. Mylan Latest Developments

Table 90. AstraZeneca Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 91. AstraZeneca Influenza Vaccine Product Offered

Table 92. AstraZeneca Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 93. AstraZeneca Main Business

Table 94. AstraZeneca Latest Developments

Table 95. Pfizer Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 96. Pfizer Influenza Vaccine Product Offered

Table 97. Pfizer Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 98. Pfizer Main Business

Table 99. Pfizer Latest Developments

Table 100. Johnson & Johnson Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 101. Johnson & Johnson Influenza Vaccine Product Offered

Table 102. Johnson & Johnson Influenza Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)

Table 103. Johnson & Johnson Main Business

Table 104. Johnson & Johnson Latest Developments

List of Figures

Figure 1. Picture of Influenza Vaccine

Figure 2. Influenza Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Influenza Vaccine Sales Growth Rate 2016-2026 (K Doses)

Figure 7. Global Influenza Vaccine Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Influenza Vaccine Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Whole Virus Vaccines

Figure 10. Product Picture of Split Virus Vaccines

Figure 11. Product Picture of Subunit Vaccines

Figure 12. Product Picture of Live Attenuated Virus Vaccines

Figure 13. Global Influenza Vaccine Sales Market Share by Type in 2020

Figure 14. Global Influenza Vaccine Revenue Market Share by Type (2016-2021)

Figure 15. Influenza Vaccine Consumed in For Children (6 months to 3 years)

Figure 16. Global Influenza Vaccine Market: For Children (6 months to 3 years) (2016-2021) & (K Doses)

Figure 17. Influenza Vaccine Consumed in For Adults and Children over 3 years

Figure 18. Global Influenza Vaccine Market: For Adults and Children over 3 years (2016-2021) & (K Doses)

Figure 19. Global Influenza Vaccine Sales Market Share by Application (2016-2021)

Figure 20. Global Influenza Vaccine Revenue Market Share by Application in 2020

Figure 21. Global Influenza Vaccine Revenue Market by Company in 2020 ($ Million)

Figure 22. Global Influenza Vaccine Revenue Market Share by Company in 2020

Figure 23. Global Influenza Vaccine Sales Market Share by Regions (2016-2021)

Figure 24. Global Influenza Vaccine Revenue Market Share by Region in 2020

Figure 25. Americas Influenza Vaccine Sales 2016-2021 (K Doses)

Figure 26. Americas Influenza Vaccine Revenue 2016-2021 ($ Millions)

Figure 27. APAC Influenza Vaccine Sales 2016-2021 (K Doses)

Figure 28. APAC Influenza Vaccine Revenue 2016-2021 ($ Millions)

Figure 29. Europe Influenza Vaccine Sales 2016-2021 (K Doses)

Figure 30. Europe Influenza Vaccine Revenue 2016-2021 ($ Millions)

Figure 31. Middle East & Africa Influenza Vaccine Sales 2016-2021 (K Doses)

Figure 32. Middle East & Africa Influenza Vaccine Revenue 2016-2021 ($ Millions)

Figure 33. Americas Influenza Vaccine Sales Market Share by Country in 2020

Figure 34. Americas Influenza Vaccine Revenue Market Share by Country in 2020

Figure 35. Americas Influenza Vaccine Sales Market Share by Type in 2020

Figure 36. Americas Influenza Vaccine Sales Market Share by Application in 2020

Figure 37. United States Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 38. Canada Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 39. Mexico Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 40. Brazil Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 41. APAC Influenza Vaccine Sales Market Share by Region in 2020

Figure 42. APAC Influenza Vaccine Revenue Market Share by Regions in 2020

Figure 43. APAC Influenza Vaccine Sales Market Share by Type in 2020

Figure 44. APAC Influenza Vaccine Sales Market Share by Application in 2020

Figure 45. China Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 46. Japan Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 47. Korea Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 48. Southeast Asia Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 49. India Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 50. Australia Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 51. Europe Influenza Vaccine Sales Market Share by Country in 2020

Figure 52. Europe Influenza Vaccine Revenue Market Share by Country in 2020

Figure 53. Europe Influenza Vaccine Sales Market Share by Type in 2020

Figure 54. Europe Influenza Vaccine Sales Market Share by Application in 2020

Figure 55. Germany Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 56. France Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 57. UK Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 58. Italy Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 59. Russia Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 60. Middle East & Africa Influenza Vaccine Sales Market Share by Country in 2020

Figure 61. Middle East & Africa Influenza Vaccine Revenue Market Share by Country in 2020

Figure 62. Middle East & Africa Influenza Vaccine Sales Market Share by Type in 2020

Figure 63. Middle East & Africa Influenza Vaccine Sales Market Share by Application in 2020

Figure 64. Egypt Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 65. South Africa Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 66. Israel Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 67. Turkey Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 68. GCC Country Influenza Vaccine Revenue Growth 2016-2021 ($ Millions)

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles